[Table/Fig-1]:
Clinical and biochemical characteristics of the study population (median, 25th-75th percentile)
| Diabetic subjects (n=121) | Controls (n=121) | p value | |
|---|---|---|---|
| Age (years) | 54.00 (45.00-59.00) | 54.00 (38.50-62.00) | .851 |
| Duration (years) | 4.00 (1.50-8.00) | - | - |
| Men/Women | 60/61 | 60/61 | - |
| BMI (kg/m2) | 25.38 (23.34-27.07) | 23.11 (21.95-24.30) | <.001 |
| Waist/Hip | 0.915 (0.88-0.97) | 0.87 (0.82-0.92) | <.001 |
| SBP (mmHg) | 128.00 (120.00-130.00) | 125.00 (120.00-128.00) | .035 |
| DBP (mmHg) | 80.00 (76.00-80.00) | 76.00 (74.00-80.00) | <.001 |
| TC (mmol/l) | 5.00 (4.50-5.85) | 3.80 (3.15-4.50) | <.001 |
| Tg (mmol/l) | 2.00 (1.50-3.10) | 1.30 (1.10-1.70) | <.001 |
| HDLC (mmol/l) | 1.00 (0.80-1.20) | 1.30 (1.20-1.40) | <.001 |
| LDLC (mmol/l) | 3.19 (2.43-3.74) | 1.97 (1.22-2.73) | <.001 |
| FBG (mmol/l) | 7.40 (6.35-10.00) | 5.20 (4.50-6.35) | <.001 |
| C-Peptide (ng/ml) | 2.40 (2.00-3.20) | 1.50 (1.20-2.00) | <.001 |
| HOMA2-IR | 2.20 (1.65-2.80) | 1.00 (0.90-1.40) | <.001 |
| hsCRP (mg/l) | 3.00 (2.00-4.35) | 2.00 (1.25-3.00) | <.001 |
BMI: body mass index, SBP: systolic blood pressure, DBP: diastolic blood pressure, TC: total cholesterol, Tg: triglycerides, HDLC: high density lipoprotein cholesterol, LDLC: low density lipoprotein cholesterol, FBG: fasting blood glucose, HOMA2-IR: homeostasis model assessment of insulin resistance, hsCRP: high sensitivity C-reactive protein.